Kyriaco did you see AGN announcement this morning? FDA hate glutamate receptors antagonist on the risk of side effects and complications and require a lot of data on that safety. NYR completely avoids this problem and brings out the same outcome with a wider indication space and avoids glutamate completely
Ann: Notice of Change of Interests of Substantial Holder - M Azzi, page-12
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.010(5.00%) |
Mkt cap ! $44.29M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.5¢ | 20.0¢ | $240.0K | 1.154M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5466 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 269720 | 5 |
View Market Depth
| Last trade - 13.17pm 17/06/2025 (20 minute delay) ? |
| NYR (ASX) Chart |